Tag Archives: LFVN

Hot Growth Stocks To Own Right Now

Finding dividend stocks that provide the right amount of growth, long-term stability, and consistent yields can be difficult. But they aren’t impossible to find, if you know where to look.

To help you track down a few of these companies for your portfolio, we reached out to some Motley Fool contributors for dividend stock ideas. They came back with these stocks. Here’s why.

Hot Growth Stocks To Own Right Now: Cara Therapeutics, Inc.(CARA)

Cara Therapeutics (NASDAQ:CARA) had its price target lifted by HC Wainwright from $24.00 to $26.00 in a research report sent to investors on Thursday, Marketbeat.com reports. They currently have a buy rating on the biopharmaceutical company’s stock.

Other equities research analysts also recently issued reports about the stock. Seaport Global Securities reiterated a buy rating on shares of Cara Therapeutics in a report on Friday, March 16th. Laidlaw set a $26.00 price target on shares of Cara Therapeutics and gave the stock a buy rating in a report on Thursday, May 24th. Stifel Nicolaus lifted their price target on shares of Cara Therapeutics to $20.00 and gave the stock a buy rating in a report on Wednesday, May 23rd. Needham & Company LLC lifted their price target on shares of Cara Therapeutics from $23.00 to $28.00 and gave the stock a buy rating in a report on Wednesday. Finally, BidaskClub downgraded shares of Cara Therapeutics from a hold rating to a sell rating in a report on Tuesday, March 20th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $24.63.

Hot Growth Stocks To Own Right Now: Lifevantage Corporation(LFVN)

investorplace.com/wp-content/uploads/2018/06/lfvn0614-300×183.png 300w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-200×122.png 200w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-400×245.png 400w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-116×71.png 116w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-100×61.png 100w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-82×50.png 82w, investorplace.com/wp-content/uploads/2018/06/lfvn0614-78×48.png 78w” sizes=”(max-width: 520px) 100vw, 520px” style=”margin: 0px 0px 18px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: Arial, Helvetica, sans-serif; vertical-align: baseline; outline: 0px; background: transparent; height: auto; max-width: 100%; width: auto;” />

LifeVantage Corp (NASDAQ:LFVN) shares have rallied nearly 70% from the lows seen in April to challenge the highs seen late last year.

The company develops nutritional supplements and skin care products such as LifeVantage TrueScience (an anti-aging skin product) and Axio energy drink all appealing to “biohackers” trying to take maximum control over their body and health. All on a monthly recurring payment plan.

With wages poised to push higher, consumers will have extra cash to burn on luxuries like non-FDA approved supplements and cremes.